DARU-Journal of Pharmaceutical Sciences

Papers
(The H4-Index of DARU-Journal of Pharmaceutical Sciences is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Hybrid derivatives containing dimethyl fumarate and benzothiazole scaffolds for the potential treatment of multiple sclerosis; in silico & in vivo study44
Multi-functionalization of reduced graphene oxide nanosheets for tumor theragnosis: Synthesis, characterization, enzyme assay, in-silico study, radiolabeling and in vivo targeting evaluation30
Dispersive micro-solid phase extraction based on two MOFs as highly effective adsorbents for analysis of nilotinib in plasma and wastewater25
Colistin induced acute kidney injury in critically ill children: a prospective study utilizing RIFLE criteria22
Lipid nanoparticles for gene therapy in ocular diseases19
Co-delivery of SN38 and rapamycin albumin bound nanoparticles against breast Cancer18
Effect of vitamins C and E on cancer survival; a systematic review17
Management and control of intraocular pressure applying macitentan hydrogel film formulation: improved effect of surfactant and cosurfactant system17
Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis16
Successful treatment of acute-on-chronic liver failure secondary to alcoholic cirrhosis with glucocorticoids and albumin: a case report16
Pharmacogenetic DPYD allele variant frequencies: A comprehensive analysis across an ancestrally diverse Iranian population14
Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations13
Novel benzimidazole derivatives; synthesis, bioactivity and molecular docking study as potent urease inhibitors13
Stearyl amine tailored spanlastics embedded within tetronic® nanogel for boosting the repurposed anticancer potential of mebendazole: formulation, in vitro profiling, cytotoxicity assessment, and in v13
Investigation of the potential therapeutic effect of cationic lipoplex mediated fibroblast growth factor-2 encoding plasmid DNA delivery on wound healing13
0.018358945846558